ALO212, umbilical cord blood-derived stem cell concentrate for vascular diseases

ALO212 is a stem cell concentrate derived from human umbilical cord blood (UCB) and expanded by NANEX™ technology. The cells are used with a platelet-rich plasma (PRP) gel for the treatment of critical limb ischemia and peripheral vascular disease. The PRP and concentrated cells are prepared by using the Magellan® System.